248 related articles for article (PubMed ID: 11029057)
1. Rotational coupling of the transmembrane and kinase domains of the Neu receptor tyrosine kinase.
Bell CA; Tynan JA; Hart KC; Meyer AN; Robertson SC; Donoghue DJ
Mol Biol Cell; 2000 Oct; 11(10):3589-99. PubMed ID: 11029057
[TBL] [Abstract][Full Text] [Related]
2. Activation of Neu (ErbB-2) mediated by disulfide bond-induced dimerization reveals a receptor tyrosine kinase dimer interface.
Burke CL; Stern DF
Mol Cell Biol; 1998 Sep; 18(9):5371-9. PubMed ID: 9710621
[TBL] [Abstract][Full Text] [Related]
3. Transmembrane domain sequence requirements for activation of the p185c-neu receptor tyrosine kinase.
Chen LI; Webster MK; Meyer AN; Donoghue DJ
J Cell Biol; 1997 May; 137(3):619-31. PubMed ID: 9151669
[TBL] [Abstract][Full Text] [Related]
4. High-throughput selection of transmembrane sequences that enhance receptor tyrosine kinase activation.
He L; Hoffmann AR; Serrano C; Hristova K; Wimley WC
J Mol Biol; 2011 Sep; 412(1):43-54. PubMed ID: 21767549
[TBL] [Abstract][Full Text] [Related]
5. Dimerization of the p185neu transmembrane domain is necessary but not sufficient for transformation.
Burke CL; Lemmon MA; Coren BA; Engelman DM; Stern DF
Oncogene; 1997 Feb; 14(6):687-96. PubMed ID: 9038376
[TBL] [Abstract][Full Text] [Related]
6. Dimer interface of transmembrane domains for neu/erbB-2 receptor dimerization and transforming activation: a model revealed by molecular dynamics simulations.
Sajot N; Genest M
J Biomol Struct Dyn; 2001 Aug; 19(1):15-31. PubMed ID: 11565846
[TBL] [Abstract][Full Text] [Related]
7. A single amino acid substitution in a WW-like domain of diverse members of the PDGF receptor subfamily of tyrosine kinases causes constitutive receptor activation.
Irusta PM; DiMaio D
EMBO J; 1998 Dec; 17(23):6912-23. PubMed ID: 9843497
[TBL] [Abstract][Full Text] [Related]
8. Strong oligomerization behavior of PDGFbeta receptor transmembrane domain and its regulation by the juxtamembrane regions.
Oates J; King G; Dixon AM
Biochim Biophys Acta; 2010 Mar; 1798(3):605-15. PubMed ID: 20036637
[TBL] [Abstract][Full Text] [Related]
9. Transmembrane domain-mediated orientation of receptor monomers in active VEGFR-2 dimers.
Dosch DD; Ballmer-Hofer K
FASEB J; 2010 Jan; 24(1):32-8. PubMed ID: 19726758
[TBL] [Abstract][Full Text] [Related]
10. Specific locations of hydrophilic amino acids in constructed transmembrane ligands of the platelet-derived growth factor beta receptor.
Freeman-Cook LL; Edwards AP; Dixon AM; Yates KE; Ely L; Engelman DM; Dimaio D
J Mol Biol; 2005 Jan; 345(4):907-21. PubMed ID: 15588835
[TBL] [Abstract][Full Text] [Related]
11. Transmembrane interactions in the activation of the Neu receptor tyrosine kinase.
Smith SO; Smith C; Shekar S; Peersen O; Ziliox M; Aimoto S
Biochemistry; 2002 Jul; 41(30):9321-32. PubMed ID: 12135353
[TBL] [Abstract][Full Text] [Related]
12. The single transmembrane domains of ErbB receptors self-associate in cell membranes.
Mendrola JM; Berger MB; King MC; Lemmon MA
J Biol Chem; 2002 Feb; 277(7):4704-12. PubMed ID: 11741943
[TBL] [Abstract][Full Text] [Related]
13. Multiple transmembrane amino acid requirements suggest a highly specific interaction between the bovine papillomavirus E5 oncoprotein and the platelet-derived growth factor beta receptor.
Nappi VM; Petti LM
J Virol; 2002 Aug; 76(16):7976-86. PubMed ID: 12134002
[TBL] [Abstract][Full Text] [Related]
14. Modulation of Transmembrane Domain Interactions in Neu Receptor Tyrosine Kinase by Membrane Fluidity and Cholesterol.
Hasan M; Patel D; Ellis N; Brown SP; Lewandowski JR; Dixon AM
J Membr Biol; 2019 Oct; 252(4-5):357-369. PubMed ID: 31222471
[TBL] [Abstract][Full Text] [Related]
15. Specific inhibition of a pathogenic receptor tyrosine kinase by its transmembrane domain.
He L; Shobnam N; Hristova K
Biochim Biophys Acta; 2011 Jan; 1808(1):253-9. PubMed ID: 20713021
[TBL] [Abstract][Full Text] [Related]
16. Activation of phosphatidylinositol 3-kinase is necessary for differentiation of FDC-P1 cells following stimulation of type III receptor tyrosine kinases.
Kubota Y; Angelotti T; Niederfellner G; Herbst R; Ullrich A
Cell Growth Differ; 1998 Mar; 9(3):247-56. PubMed ID: 9543391
[TBL] [Abstract][Full Text] [Related]
17. Definition of an inhibitory juxtamembrane WW-like domain in the platelet-derived growth factor beta receptor.
Irusta PM; Luo Y; Bakht O; Lai CC; Smith SO; DiMaio D
J Biol Chem; 2002 Oct; 277(41):38627-34. PubMed ID: 12181311
[TBL] [Abstract][Full Text] [Related]
18. A putative molecular-activation switch in the transmembrane domain of erbB2.
Fleishman SJ; Schlessinger J; Ben-Tal N
Proc Natl Acad Sci U S A; 2002 Dec; 99(25):15937-40. PubMed ID: 12461170
[TBL] [Abstract][Full Text] [Related]
19. Receptor tyrosine kinase transmembrane domains: Function, dimer structure and dimerization energetics.
Li E; Hristova K
Cell Adh Migr; 2010; 4(2):249-54. PubMed ID: 20168077
[TBL] [Abstract][Full Text] [Related]
20. Leucine motif-dependent tyrosine autophosphorylation of type III receptor tyrosine kinases.
Meyer RD; Qian X; Guo HC; Rahimi N
J Biol Chem; 2006 Mar; 281(13):8620-7. PubMed ID: 16431914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
